nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—SCN3A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.102	0.116	CbGpPWpGaD
Prilocaine—SCN2A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0983	0.112	CbGpPWpGaD
Prilocaine—SCN1A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0948	0.108	CbGpPWpGaD
Prilocaine—SCN5A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0666	0.0758	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0393	0.0446	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0377	0.0429	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0364	0.0414	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0256	0.0291	CbGpPWpGaD
Prilocaine—Acidosis—Metformin—polycystic ovary syndrome	0.0175	0.146	CcSEcCtD
Prilocaine—SCN3A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.0155	0.0176	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.0149	0.0169	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.0148	0.0169	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.0144	0.0163	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.0143	0.0162	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.0137	0.0156	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CDH15—polycystic ovary syndrome	0.013	0.0148	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CDH15—polycystic ovary syndrome	0.0125	0.0142	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CDH15—polycystic ovary syndrome	0.012	0.0137	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—NRG1—polycystic ovary syndrome	0.0119	0.0136	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.0106	0.012	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.0104	0.0118	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.0102	0.0116	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.0101	0.0115	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00981	0.0112	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00966	0.011	CbGpPWpGaD
Prilocaine—Neuropathy—Metformin—polycystic ovary syndrome	0.00912	0.0757	CcSEcCtD
Prilocaine—Lightheadedness—Metformin—polycystic ovary syndrome	0.00869	0.0721	CcSEcCtD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—INS—polycystic ovary syndrome	0.00855	0.00973	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00846	0.00962	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—IGF1—polycystic ovary syndrome	0.00827	0.00941	CbGpPWpGaD
Prilocaine—Injury—Metformin—polycystic ovary syndrome	0.00767	0.0637	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.0069	0.00784	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.0066	0.0075	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00587	0.00667	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—DLG4—polycystic ovary syndrome	0.00586	0.00666	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—DLG4—polycystic ovary syndrome	0.00563	0.0064	CbGpPWpGaD
Prilocaine—Drowsiness—Metformin—polycystic ovary syndrome	0.00544	0.0451	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—DLG4—polycystic ovary syndrome	0.00543	0.00617	CbGpPWpGaD
Prilocaine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00533	0.0442	CcSEcCtD
Prilocaine—Bradycardia—Metformin—polycystic ovary syndrome	0.00497	0.0412	CcSEcCtD
Prilocaine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00485	0.0403	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00475	0.0054	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00418	0.00476	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00415	0.00472	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00402	0.00457	CbGpPWpGaD
Prilocaine—Vision blurred—Metformin—polycystic ovary syndrome	0.004	0.0332	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00399	0.00453	CbGpPWpGaD
Prilocaine—Tremor—Metformin—polycystic ovary syndrome	0.00398	0.033	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00392	0.00446	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00387	0.00441	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00384	0.00437	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—DLG4—polycystic ovary syndrome	0.00382	0.00434	CbGpPWpGaD
Prilocaine—Syncope—Metformin—polycystic ovary syndrome	0.00381	0.0316	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00376	0.00428	CbGpPWpGaD
Prilocaine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00373	0.031	CcSEcCtD
Prilocaine—Hypertension—Metformin—polycystic ovary syndrome	0.00367	0.0304	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00363	0.00413	CbGpPWpGaD
Prilocaine—Oedema—Metformin—polycystic ovary syndrome	0.00347	0.0288	CcSEcCtD
Prilocaine—Shock—Metformin—polycystic ovary syndrome	0.00341	0.0283	CcSEcCtD
Prilocaine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.0034	0.0282	CcSEcCtD
Prilocaine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00335	0.0278	CcSEcCtD
Prilocaine—Hypotension—Metformin—polycystic ovary syndrome	0.00324	0.0269	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00313	0.00356	CbGpPWpGaD
Prilocaine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00311	0.0258	CcSEcCtD
Prilocaine—Somnolence—Metformin—polycystic ovary syndrome	0.00308	0.0256	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00301	0.00342	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.0029	0.0033	CbGpPWpGaD
Prilocaine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00286	0.0237	CcSEcCtD
Prilocaine—Urticaria—Metformin—polycystic ovary syndrome	0.00275	0.0228	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00272	0.0031	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.0027	0.00307	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—LEP—polycystic ovary syndrome	0.00258	0.00293	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00255	0.0029	CbGpPWpGaD
Prilocaine—Asthenia—Metformin—polycystic ovary syndrome	0.00249	0.0206	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—LEP—polycystic ovary syndrome	0.00248	0.00282	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—LEP—polycystic ovary syndrome	0.00239	0.00272	CbGpPWpGaD
Prilocaine—Dizziness—Metformin—polycystic ovary syndrome	0.00229	0.019	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.00228	0.00259	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00225	0.00255	CbGpPWpGaD
Prilocaine—Vomiting—Metformin—polycystic ovary syndrome	0.0022	0.0183	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—INS—polycystic ovary syndrome	0.0022	0.0025	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00216	0.00245	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00213	0.00242	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—INS—polycystic ovary syndrome	0.00212	0.00241	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00208	0.00236	CbGpPWpGaD
Prilocaine—Nausea—Metformin—polycystic ovary syndrome	0.00206	0.0171	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00204	0.00233	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00204	0.00232	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—INS—polycystic ovary syndrome	0.00204	0.00232	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00197	0.00224	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—VEGFA—polycystic ovary syndrome	0.00195	0.00222	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—VEGFA—polycystic ovary syndrome	0.00187	0.00213	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—VEGFA—polycystic ovary syndrome	0.00181	0.00205	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—LEP—polycystic ovary syndrome	0.00168	0.00191	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.00158	0.00179	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00146	0.00166	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—INS—polycystic ovary syndrome	0.00143	0.00163	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.00139	0.00158	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00139	0.00158	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—IL6—polycystic ovary syndrome	0.00135	0.00153	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.00134	0.00152	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—IL6—polycystic ovary syndrome	0.0013	0.00147	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.00129	0.00147	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—VEGFA—polycystic ovary syndrome	0.00127	0.00144	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—IL6—polycystic ovary syndrome	0.00125	0.00142	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—IL6—polycystic ovary syndrome	0.000962	0.00109	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—IL6—polycystic ovary syndrome	0.000924	0.00105	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000906	0.00103	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—IL6—polycystic ovary syndrome	0.000891	0.00101	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	0.000878	0.000999	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	0.000627	0.000713	CbGpPWpGaD
